K2M Funds Its Focus On The Complex Spine With IPO

The 10-year-old spine firm initiated its initial public offering this month, transforming from the largest private spine device firm to another public player in a highly competitive market. CEO Eric Major K2M’s focus on complex spinal deformities will help distinguish it from the pack.

Link:
K2M Funds Its Focus On The Complex Spine With IPO

Tags: diagnostics, qdss

This entry was posted on Tuesday, May 20th, 2014 at 2:46 pm by admin and is filed under Needlestick Statistics, Syringes. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.